ScholarWorks@Hanyang University

Browsing by Lim, Yu-CheolAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 4 of 4

SCIESCOPUS
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing SpondylitisGo to Linkopen access

Koo, Bon San; Lim, Yu-Cheol; Lee, Min-Young; Jeon, Ja-Young; Yoo, Hyun-Jeong; Oh, In-Sun; Shin, Ju-Young; Kim, Tae-Hwan

ArticleIssue Date2021CitationRHEUMATOLOGY AND THERAPY, v.8, no.1, pp.347 - 359PublisherSPRINGER
SCIESCOPUS
Tapering of Tumor Necrosis Factor Inhibitor and Healthcare Cost Differences in Patients with Ankylosing Spondylitis: A Retrospective Analysis of Korean National Health Insurance DataGo to Link

Koo, Bon San; Lim, Yu-Cheol; Lee, Min-Young; Jeon, Ja-Young; Yoo, Hyun-Jeong; Oh, In-Sun; Shin, Ju-Young; Kim, Tae-Hwan

ArticleIssue Date2019CitationARTHRITIS & RHEUMATOLOGY, v.71PublisherWILEY
SCIESCOPUS
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitorsGo to Link

Koo, Bon San; Lim, Yu-Cheol; Lee, Min-Young; Jeon, Ja-Young; Yoo, Hyun-Jeong; Oh, In-Sun; Shin, Ju-Young; Kim, Tae-Hwan

ArticleIssue Date2021CitationMODERN RHEUMATOLOGY, v.31, no.6, pp.1192 - 1201PublisherTAYLOR & FRANCIS LTD
SCISCIESCOPUS
THE RISK OF INFECTION BY TUMOR NECROSIS FACTOR INHIBITORS AND ITS ASSOCIATED FACTORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULT FROM KOREAN NATIONAL HEALTH INSURANCE DATAGo to Link

Koo, Bon San; Lim, Yu-Cheol; Lee, Min-Young; Jeon, Ja-Young; Yoo, Hyun-Jeong; Oh, In-Sun; Shin, Ju-Young; Lee, Eui-Kyung; Kim, Tae-Hwan

ArticleIssue Date2019CitationAnnals of the Rheumatic Diseases, v.78, pp 869 - 870PublisherBMJ Publishing Group
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어